Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study

被引：0
|
作者：
Naoki Hashimoto
Atsuhito Toyomaki
Minoru Honda
Satoru Miyano
Nobuyuki Nitta
Hiroyuki Sawayama
Yasufumi Sugawara
Keiichi Uemura
Noriko Tsukamoto
Tsukasa Koyama
Ichiro Kusumi
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Psychiatry
[2] Child and Adolescent Psychiatry,Department of Psychiatry
[3] Department of Psychiatry University of California,undefined
[4] Honda Memorial Hospital,undefined
[5] Teine Hospital,undefined
[6] Sapporo Hanazono Hospital,undefined
[7] San-ai Hospital,undefined
[8] Psychiatric Medical Center,undefined
[9] Sapporo City General Hospital,undefined
[10] Hakodate Watanabe Hospital,undefined
[11] Oyachi Hospital,undefined
来源：
Annals of General Psychiatry | / 14卷
关键词：
Schizophrenia; Quetiapine; Switching; Antipsychotic; Negative symptom; Cognitive impairment; Treatment resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study
    Hashimoto, Naoki
    Toyomaki, Atsuhito
    Honda, Minoru
    Miyano, Satoru
    Nitta, Nobuyuki
    Sawayama, Hiroyuki
    Sugawara, Yasufumi
    Uemura, Keiichi
    Tsukamoto, Noriko
    Koyama, Tsukasa
    Kusumi, Ichiro
    ANNALS OF GENERAL PSYCHIATRY, 2015, 14
  • [2] Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics
    De Nayer, A
    Irmansyah, EW
    Larmo, I
    Lindenbauer, B
    Rittmannsberger, H
    Platz, T
    Jones, AM
    Whiteford, JL
    Altman, CA
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (01) : 59 - 66
  • [3] The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population
    Pei-Yin Pan
    Meei-Shyuan Lee
    Chin-Bin Yeh
    BMC Psychiatry, 15
  • [4] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, T.
    Murray, R. M.
    Azorin, J. M.
    Maehlum, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 431 - 432
  • [5] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [6] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, A.
    Murray, R. M.
    Azorin, J. M.
    Maehium, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S113 - S113
  • [7] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
    McConville, B
    Carrero, L
    Sweitzer, D
    Potter, L
    Chaney, R
    Foster, K
    Sorter, M
    Friedman, L
    Browne, K
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
  • [8] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Michael Spaeth
    Cayetano Alegre
    Serge Perrot
    Youyu Grace Wang
    Diane R Guinta
    Sarah Alvarez-Horine
    Irwin Jon Russell
    Arthritis Research & Therapy, 15
  • [9] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Spaeth, Michael
    Alegre, Cayetano
    Perrot, Serge
    Wang, Youyu Grace
    Guinta, Diane R.
    Alvarez-Horine, Sarah
    Russell, Irwin Jon
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [10] Tolerability and safety of topiramate in chinese patients with epilepsy - An open-label, long-term, prospective study
    Lu, Yang
    Wang, Xuefeng
    Li, Qihua
    Li, Jingmei
    Yan, Yong
    CLINICAL DRUG INVESTIGATION, 2007, 27 (10) : 683 - 690
12345